Pharmacology Book

Additive

  • Caffeine

Fiber

Fruit

Phytoestrogens

Preservative

Protein

Information Resources

//fpnotebook.com/

Caffeine

Aka: Caffeine, Caffeine Overdose, Caffeine Toxicity, Guaranine, Theine
  1. See Also
    1. Unknown Ingestion
  2. Indications
    1. Central Nervous System Stimulant
      1. Caffeine is the most widely used psychoactive substance in the world
      2. Daly (1998) Lakartidningen 95(51-52):5878-83 [PubMed]
    2. Idiopathic Apnea of Prematurity
      1. Increases central inspiratory drive
      2. Increases carbon dioxide sensitivity at respiratory centers in Medulla
      3. Increases skeletal Muscle contractility (including respiratory Muscles)
    3. Sports Performance Supplement (Ergogenic Aid)
      1. Athletes are limited to 12-15 mcg/ml urine depending on regulatory agency (NCAA, IOC)
      2. Performance enhancing in endurance sports
  3. Preparations: Relative Caffeine amounts
    1. 10 mg/serving
      1. Decaffeinated coffee (7 oz, 210 ml)
      2. Milk chocolate (1.5 oz)
    2. 30 mg/serving
      1. Dark chocolate (1.5 oz)
    3. 50 mg/serving
      1. Tea (8 oz, 240 ml)
      2. Caffeinated soda (12 oz, 360 ml)
      3. Coffee ice cream (8 oz, 240 ml)
    4. 100 mg/serving
      1. Coffee (8 oz, 240 ml)
    5. 150 mg/serving
      1. Expresso (2 oz, 60 ml)
    6. 250-350 mg/serving
      1. Energy Drinks (8-16 oz, e.g. Redline, Spike, Hyde, Wired, Loud, Java Monster, Rockstar, Bang)
  4. Precautions
    1. Energy drinks contain high levels of stimulants
      1. Combined Caffeine and Methylxanthines may exceed 500 mg total
      2. Higher risk of toxicity
    2. Limit daily Caffeine below maximum
      1. Adults: 400 mg/day
      2. Teens: 2.5 mg/kg/day (up to 400 mg/day)
  5. Pathophysiology: Toxicity
    1. Adenosine Receptor Antagonist
    2. Stimulates Catecholamines (increased beta-1 and beta-2 agonist activity)
    3. Phosphodiesterase Inhibitor (increased 3-5 cAMP, increased intracellular Calcium)
  6. Pharmacokinetics
    1. Metabolism: Zero order elimination (very slow elimination)
    2. Hepatic Metabolism
    3. High oral bioavailability
    4. Oral onset of peak activity <2 hours
    5. Half-Life: 4-5 hours (as long as 60-100 hours in newborns)
    6. Volume of distribution: 0.6 to 0.7 L/kg (0.8 to 0.9 in newborns)
    7. Protein binding: 17%
    8. Concentrations
      1. Toxicity: >35 mg/kg (esp. children)
      2. Lethal Dose: 10-20 grams in an adult (>100 mg/kg)
  7. Adverse Effects: Non-toxic Ingestion
    1. Anxiety
    2. Jitteriness
    3. Arrhythmia
    4. Insomnia
  8. Adverse Effects: Toxic Levels
    1. General
      1. Hypothermia
    2. Cardiopulmonary
      1. Respiratory Depression
      2. Dysrhythmia (e.g. Multifocal Atrial Tachycardia)
      3. Hypertension
      4. Wide Pulse Pressure (with diastolic Hypotension)
    3. Gastrointestinal
      1. Nausea
      2. Vomiting
    4. Neuropsychiatric
      1. Anxiety
      2. Tremor
      3. Seizures
  9. Labs: Toxicity
    1. Consider evaluation for Unknown Ingestion
    2. Caffeine concentration is not typically available outside tertiary centers
    3. Basic Chemistry Panel
      1. Hypokalemia
      2. Metabolic Acidosis
      3. Hyperglycemia
  10. Management: Severe Caffeine Toxicity or Overdose
    1. General
      1. Consider other ingestions
      2. Consider Poison Control Consultation
    2. Antidotes
      1. Consider Activated Charcoal after recent known large ingestion
      2. Consider Intralipid (20% lipid emulsion) 1.5 mg/kg for refractory Hypotension or tachydysrhythmia
    3. Supportive care
      1. ABC Management
      2. Vasopressors for Hypotension (e.g. Norepinephrine, Vasopressin)
      3. Consider Esmolol infusion for tachydysrhythmia (Exercise caution)
      4. Consider Benzodiazepines for Agitation
    4. Hemodialysis Indications
      1. Seizures
      2. refractory Hypotension or tachydysrhythmia
      3. Caffeine concentration at toxic levels (>100 mg/L acutely, >60 mg/L chronically)
    5. Discharge Indications
      1. Asymptomatic at 4-6 hours after ingestion
  11. Resources
    1. FDA News: Investigation into Energy Drinks and Supplements
      1. http://www.fda.gov/Food/NewsEvents/ucm328536.htm
  12. References
    1. Leikin (1996) Poisoning and Toxicology Handbook, Lexicomp, Hudson, Ohio, p. 175-7
    2. Nordt in Herbert (2012) EM: Rap 12(8): 5
    3. Tomaszewski (2019) Crit Dec Emerg Med 33(12): 32

Caffeine overdose (C0573204)

Concepts Injury or Poisoning (T037)
SnomedCT 296329002
English caffeine overdose, Caffeine overdose, Caffeine overdose (disorder)
Spanish sobredosis de cafeína (trastorno), sobredosis de cafeína
Sources
Derived from the NIH UMLS (Unified Medical Language System)


caffeine stimulant related disorder (C2919093)

Concepts Disease or Syndrome (T047)
ICD10 F15
English caffeine, caffeine stimulant related disorder
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree